The DOI matches its Crossref record; 153 of the 156 references it cites were found in a registry or an index.
Adherence interventions and outcomes of tuberculosis treatment: A systematic review and meta-analysis of trials and observational studies
Open accessAbstract
BACKGROUND: Incomplete adherence to tuberculosis (TB) treatment increases the risk of delayed culture conversion with continued transmission in the community, as well as treatment failure, relapse, and development or amplification of drug resistance. We conducted a systematic review and meta-analysis of adherence interventions, including directly observed therapy (DOT), to determine which approaches lead to improved TB treatment outcomes. METHODS AND FINDINGS: We systematically reviewed Medline as well as the references of published review articles for relevant studies of adherence to multidrug treatment of both drug-susceptible and drug-resistant TB through February 3, 2018. We included randomized controlled trials (RCTs) as well as prospective and retrospective cohort studies (CSs) with an internal or external control group that evaluated any adherence intervention and conducted a meta-analysis of their impact on TB treatment outcomes. Our search identified 7,729 articles, of which 129 met the inclusion criteria for quantitative analysis. Seven adherence categories were identified, including DOT offered by different providers and at various locations, reminders and tracers, incentives and enablers, patient education, digital technologies (short message services [SMSs] via mobile phones and video-observed therapy [VOT]), staff education, and combinations of these interventions. When compared with DOT alone, self-administered therapy (SAT) was associated with lower rates of treatment success (CS: risk ratio [RR] 0.81, 95% CI 0.73-0.89; RCT: RR 0.94, 95% CI 0.89-0.98), adherence (CS: RR 0.83, 95% CI 0.75-0.93), and sputum smear conversion (RCT: RR 0.92, 95% CI 0.87-0.98) as well as higher rates of development of drug resistance (CS: RR 4.19, 95% CI 2.34-7.49). When compared to DOT provided by healthcare providers, DOT provided by family members was associated with a lower rate of adherence (CS: RR 0.86, 95% CI 0.79-0.94). DOT delivery in the community versus at the clinic was associated with a higher rate of treatment success (CS: RR 1.08, 95% CI 1.01-1.15) and sputum conversion at the end of two months (CS: RR 1.05, 95% CI 1.02-1.08) as well as lower rates of treatment failure (CS: RR 0.56, 95% CI 0.33-0.95) and loss to follow-up (CS: RR 0.63, 95% CI 0.40-0.98). Medication monitors improved adherence and treatment success and VOT was comparable with DOT. SMS reminders led to a higher treatment completion rate in one RCT and were associated with higher rates of cure and sputum conversion when used in combination with medication monitors. TB treatment outcomes improved when patient education, healthcare provider education, incentives and enablers, psychological interventions, reminders and tracers, or mobile digital technologies were employed. Our findings are limited by the heterogeneity of the included studies and lack of standardized research methodology on adherence interventions. CONCLUSION: TB treatment outcomes are improved with the use of adherence interventions, such as patient education and counseling, incentives and enablers, psychological interventions, reminders and tracers, and digital health technologies. Trained healthcare providers as well as community delivery provides patient-centered DOT options that both enhance adherence and improve treatment outcomes as compared to unsupervised, SAT alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



























Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The consequences of poor adherence include delayed sputum culture conversion, treatment failure, relapse, prolonged infectiousness, development of drug resistance, and increased morbidity and mortality [4,5].”
From Psychosocial Interventions for Improving Treatment Adherence in Tuberculosis Patients: A Scoping Review of Evidence-Based Approaches. (2026) · cites this paper as [4]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Previous research has indicated that treatment adherence interventions (eg, patient counselling and education, reminders, and digital health technologies)47, 48 and social protection interventions (eg, cash transfers and economic incentives)49, 50 can increase treatment adherence and prevent mortality.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
(2014) · Medical Entomology and Zoology · Cited by 17,633
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(04)17670-8 · Cited by 2,544
Free, C., Phillips, G., Galli, L., Watson, L., Felix, L., Edwards, P., Patel, V., & Haines, A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001362 · Cited by 1,766 · cited 1×
“Psychological interventions aim to support via psychological or emotional counseling or a social network of peers undergoing TB treatment as a means of improving adherence to TB treatment [18,19].”
BackgroundNahid, P., Dorman, S. E., Alipanah, N., Barry, P. M., Brozek, J. L., Cattamanchi, A., Chaisson, L. H., Chaisson, R. E., Daley, C. L., Grzemska, M., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw376 · Cited by 1,170
Self-citationPatient Adherence to Tuberculosis Treatment: A Systematic Review of Qualitative Research
Munro, S. A., Lewin, S. A., Smith, H. J., Engel, M. E., Fretheim, A., & Volmink, J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040238 · Cited by 1,080
Assessing the Gold Standard — Lessons from the History of RCTs
Bothwell, L. E., Greene, J. A., Podolsky, S. H., & Jones, D. S. (2016) · New England Journal of Medicine · doi:10.1056/nejmms1604593 · Cited by 664
Directly observed therapy for treating tuberculosis
Karumbi, J., & Garner, P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003343.pub4 · Cited by 644
The Effect of Directly Observed Therapy on the Rates of Drug Resistance and Relapse in Tuberculosis
Weis, S. E., Slocum, P. C., Blais, F. X., King, B., Nunn, M., Matney, G. B., Gomez, E., & Foresman, B. H. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404283301702 · Cited by 589 · cited 2×
“Only three CSs compared the impact of DOT on the development of drug resistance compared with SAT, one of which found no significant difference [4,59,70].”
BackgroundResultOrenstein, E. W., Basu, S., Shah, N. S., Andrews, J. R., Friedland, G. H., Moll, A. P., Gandhi, N. R., & Galvani, A. P. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70041-6 · Cited by 540
Research works printed but not linked: 7
- Alipanah N, Jarlsberg L, Miller C, Lechner A, Wai K, Nahid P. Report for Systematic Review for Adherence Interventions in TB Treatment. World Health Organization guidelines for treatment of drug-susceptible tuberculosis and patient care. 2017;Annex 5.
- 2014, Review Manager (RevMan)
- T Chennai, 1997, A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis, Tuberculosis Research Centre. Int J Tuberc Lung Dis, 1, 509
- AA Vieira, 2011, Compliance with tuberculosis treatment after the implementation of the directly observed treatment, short-course strategy in the city of Carapicuiba, Brazil, J Bras Pneumol, 37, 223
- VK Arora, 2003, Community mediated domiciliary DOTS execution—A study from New Delhi, Ind J Tub, 50, 143
- JP Cantalice Filho, 2009, Food baskets given to tuberculosis patients at a primary health care clinic in the city of Duque de Caxias, Brazil: effect on treatment outcomes, J Bras Pneumol, 35, 992
- RP Paramasivan, 1993, Short course chemotherapy: A controlled study of indirect default retrieval method, Ind J Tub, 40, 185
Cited by
Items 401–500 of 503
Medication Adherence Behavior Among Patients with Pulmonary Tuberculosis (TB) in West Sumba
Fretes, F. D., Putri, A. R. E., & Sanubari, T. P. E. (2024) · JKEP · doi:10.32668/jkep.v9i1.1201
Amoo, O. S., Kareithi, D. N., Tijani, B., Onuigbo, T. I., Karera, S., Oladejo, B., Oraegbu, J. I., Ezike, J., Adekoya, A. M., Sani, M., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4468501/v1
Validação do aplicativo móvel TBApp para a gestão do autocuidado de pessoas com tuberculose
de Assis, L. B. D. O., da Silva, D. M. G. V., da Silva, J. M., dos Santos, E. R., Pinheiro, J. D. S., Sacramento, D. S., de Oliveira, H. J. H., & Sicsú, A. N. (2024) · Revista Brasileira de Enfermagem · doi:10.1590/0034-7167-2023-0195 · Cited by 2
“…the use of adherence interventions such as education, reminders and digital health technologies, which reinforces the importance of the TBApp developed, as it brings reminders to take medication and motivating messages as well as educational content about the disease, tests and treatment (35) .”
BackgroundEffa, E., Okpa, H. O., Onwusaka, O., Okpara, H. C., Mbu, P. N., Otokpa, D. E., & Ekrikpo, U. E. (2024) · PubMed Central · doi:10.60787/nmj-64-1-71
Perception, acceptability and challenges of digital adherence technology among TB healthcare workers
Gordon, I., Odume, B. B., Ogbudebe, C. L., Chukwuogo, O., Nwokoye, N. N., Useni, S., Efo, E., Gidado, M., Aniwada, E., Ihesie, A., et al. (2024) · Public Health Action · doi:10.5588/pha.24.0008 · Cited by 1
“8 These platforms have been shown to improve TB treatment success; 9,10 however, infrastructure requirements and high maintenance costs are potential hurdles to scalability and sustainability.”
BackgroundEnhancing TB treatment adherence through the application of the Behaviour Change Wheel
Matakanye, H., & Tshitangano, T. G. (2024) · Cogent Public Health · doi:10.1080/27707571.2024.2376942 · Cited by 1
Oktaviani, E., Anggadiredja, K., & Amalia, L. (2024) · Pharmacia · doi:10.3897/pharmacia.71.e118795
The role of millets in improving tuberculosis treatment
Shrivastava, D. V., & Nema, P. (2024) · International Journal of Home Science · doi:10.22271/23957476.2024.v10.i2f.1644
陈, 洁. (2024) · Hans Journal of Biomedicine · doi:10.12677/hjbm.2025.151001
Bridging the Gap: Navigating the Nexus of Tuberculosis and Mental Well-being
Danasekaran, R. (2025) · Indian Journal of Community Medicine · doi:10.4103/ijcm.ijcm_795_23
Kipkosgei, K. C., Anino, C. O., & Makalliwa, G. A. (2025) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2025.02.006
Rethinking the benefits of digital adherence technologies for tuberculosis treatment
Marx, F. M., & Civan, A. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00199-0
Pi, Y., Tan, J., Yang, P., Pan, J., Yang, X., Xiang, M., & Li, T. (2025) · Patient Preference and Adherence · doi:10.2147/ppa.s520100
“27,38 Conversely, patients with junior college education or above demonstrated greater initiative, aligning with global evidence on education’s role in health literacy (15,16).”
InfluentialGuzmán, J. A. C., Melgen, R. E., Mendoza, E. R., Arias, L. F., Espinal, R., Báez, J., & Iribarren, S. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1529687 · Cited by 1
OVAYOLU, S. A. Ö. (2025) · The National Medical Journal of India · doi:10.25259/nmji_1061_2022
Baik, Y., Musoke, M., Twinamasiko, A., Lamunu, M., Nabacwa, V., Sanyu, A. N., Robsky, K., Sung, J., Kityamuwesi, A., Katamba, A., et al. (2025) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202404-422oc
Konsequenzen der Nicht-Adhärenz und Korrelate der Adhärenz
Rapoff, M. A., Duncan, C. L., & Karlson, C. (2025) · Springer eBooks · doi:10.1007/978-3-031-86845-0_2
Rani, A. Y. A., Ismail, N. B., Zakaria, Y., & Isa, M. R. (2025) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2025.102913
Park, H., Kim, S. J., Kim, G., Chang, S., Shin, J., & Ahn, S. (2025) · Healthcare Informatics Research · doi:10.4258/hir.2025.31.3.263
Tuberculosis treatment and primary care: impact of the COVID-19 pandemic
de Souza, K. L., Takahashi, E. M., Ribeiro, S., Yamamoto, T. T., Fernandes, H., Gonzáles, R. I. C., & Hino, P. (2025) · Acta Paulista de Enfermagem · doi:10.37689/acta-ape/2025ao01253i
“(22) Finally, in a study conducted in São Paulo with the aim to evaluate the performance of the Tuberculosis Control Program in municipalities of the state, the importance of DOT in ensuring significant cure rates, reducing abandonment and the occurrence of new TB cases was reinforced.”
O tratamento da tuberculose e atenção primária: repercussão da pandemia COVID-19
de Souza, K. L., Takahashi, E. M., Ribeiro, S., Yamamoto, T. T., Fernandes, H., Gonzáles, R. I. C., & Hino, P. (2025) · Acta Paulista de Enfermagem · doi:10.37689/acta-ape/2025ao01253
Zamora, L. S. S., Vargas-Henao, N. P., Fuertes-Bucheli, J. F., Luna, L., García, P. K., Olaya, R. A., & Pacheco, R. (2025) · Revista de la Facultad de Ciencias de la Salud Universidad del Cauca · doi:10.47373/rfcs.2025.v27.2395
Public Health Strategies and Prevention of Tuberculosis
Cobelens, F. G. J. (2025) · Springer eBooks · doi:10.1007/978-3-031-94540-3_13
Bwambale, K., Nakkonde, D., Nassanga, G., Buregyeya, E., Zalwango, S. K., & Sekandi, J. N. (2025) · Research Square · doi:10.21203/rs.3.rs-7447805/v1
“Consequently, TB treatment non-adherence increases infectiousness, risk of multidrug-resistant TB (MDR-TB), and poor treatment outcomes, including higher mortality rates 7–11 .”
Richardson, S., Vorster, P., Burger, R., & Rieger, M. (2025) · doi:10.2196/preprints.85242
Jiménez, S., Rearte, A., Rearte, R., Fernández, H. F., Spirito, B., Blanco, M., Canton, M. E., Daquila, S., Ferro, L., Bossio, J. C., et al. (2025) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2025.100
Xie, F., Yao, R., Li, L., Wu, C., Hu, Y., Zhou, Y., Huang, M., Du, J., Zhao, X., Wan, B., et al. (2025) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.70280 · Cited by 3
Global Burden of Tuberculosis in Adults Aged 65 Years and Older, 1990–2021: A Population-Based StudyPreprint
Liu, Y., Zhang, C., Li, T., Fan, M., Li, Y., Chen, H., Cheng, J., Zhang, H., & Gao, Z. (2025) · Research Square · doi:10.21203/rs.3.rs-7602192/v1
Co-infection; A Neglected Health Condition in Northern Ghana in the Wake of COVID-19
Helegbe, G. K., Aryee, P. A., & Nyasulu, P. S. (2025) · Springer eBooks · doi:10.1007/978-981-95-0618-7_4
Che, L., Wang, L., & Liu, Z. (2025) · Journal of Applied Mathematics and Computing · doi:10.1007/s12190-025-02668-w
“Suboptimal adherence elevates the risks of treat-ment failure, relapse, and the emergence of drug-resistant strains [9].”
Baker, A., Gupta, A. J., Nanziri, L., Ggita, J. M., Hernandez-Ramirez, R. U., Shenoi, S. V., Ayakaka, I., Armstrong-Hough, M., Katamba, A., & Davis, J. L. (2024) · Research Square · doi:10.21203/rs.3.rs-3956897/v1
“One of the strongest predictors of treatment failure is inadequate baseline knowledge (7).”
BackgroundAdditional file 1 of Inadequate housing and pulmonary tuberculosis: a systematic review
Lee, J.-Y., Kwon, N., Goo, G.-Y., & Cho, S.-I. (2022) · Figshare · doi:10.6084/m9.figshare.19470430
Manyazewal, T., Woldeamanuel, Y., Holland, D. P., Fekadu, A., Blumberg, H. M., & Marconi, V. C. (2020) · Figshare · doi:10.6084/m9.figshare.12257729
Additional file 2 of Inadequate housing and pulmonary tuberculosis: a systematic review
Lee, J.-Y., Kwon, N., Goo, G.-Y., & Cho, S.-I. (2022) · Figshare · doi:10.6084/m9.figshare.19470433
Wekesa, C., Sekaggya‐Wiltshire, C., Muyanja, S. Z., Lume, I., Nabaggala, M. S., Parkes-Ratanshi, R., & Akello, S. A. (2023) · Figshare · doi:10.6084/m9.figshare.22814918
Li, W., Su, M., Zhang, W., Fan, X., Li, R., Gao, Y., & Wei, X. (2024) · Figshare · doi:10.6084/m9.figshare.26634645
Otero, L., Zetola, N. M., Campos, M., Zunt, J., Bayer, A. M., Curisinche, M., Ochoa, T., Reyes, M., Vega, V., Van der Stuyft, P., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26563707
Additional file 5 of Inadequate housing and pulmonary tuberculosis: a systematic review
Lee, J.-Y., Kwon, N., Goo, G.-Y., & Cho, S.-I. (2022) · Figshare · doi:10.6084/m9.figshare.19470445
Wang, N., Guo, L., Shewade, H. D., Thekkur, P., Zhang, H., Yuan, Y.-L., Wang, X.-M., Wang, X., Sun, M.-M., Huang, F., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14235066
Wang, N., Guo, L., Shewade, H. D., Thekkur, P., Zhang, H., Yuan, Y.-L., Wang, X.-M., Wang, X., Sun, M.-M., Huang, F., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14235069
Kerschberger, B., Daka, M., Shongwe, B., Dlamini, T., Ngwenya, S., Danbakli, C., Mamba, B., Nxumalo, B., Sibanda, J., Dube, S., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25963069
Bröckelmann, N., Stadelmaier, J., Harms, L., Kubiak, C., Beyerbach, J., Wolkewitz, M., Meerpohl, J. J., & Schwingshackl, L. (2022) · Figshare · doi:10.6084/m9.figshare.21385915
Manyazewal, T., Woldeamanuel, Y., Holland, D. P., Fekadu, A., Blumberg, H. M., & Marconi, V. C. (2020) · Figshare · doi:10.6084/m9.figshare.12257741
Wang, N., Guo, L., Shewade, H. D., Thekkur, P., Zhang, H., Yuan, Y.-L., Wang, X.-M., Wang, X., Sun, M.-M., Huang, F., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14235072
Additional file 3 of Inadequate housing and pulmonary tuberculosis: a systematic review
Lee, J.-Y., Kwon, N., Goo, G.-Y., & Cho, S.-I. (2022) · Figshare · doi:10.6084/m9.figshare.19470439
Bröckelmann, N., Balduzzi, S., Harms, L., Beyerbach, J., Petropoulou, M., Kubiak, C., Wolkewitz, M., Meerpohl, J. J., & Schwingshackl, L. (2022) · Figshare · doi:10.6084/m9.figshare.19746415
Jiang, W.-X., Li, Z.-P., Zhao, Q., Gao, M.-Q., Long, Q., Wang, W.-B., Huang, F., Wang, N., & Tang, S.-L. (2021) · Figshare · doi:10.6084/m9.figshare.14462767
Makabayi‐Mugabe, R., Musaazi, J., Zawedde‐Muyanja, S., Kizito, E., Namwanje, H., Aleu, P., Charlet, D., Lopez, D. B. F., Brightman, H., Turyahabwe, S., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19128565
Makabayi‐Mugabe, R., Musaazi, J., Zawedde‐Muyanja, S., Kizito, E., Fatta, K., Namwanje, H., Turyahabwe, S., & Nkolo, A. (2024) · Figshare · doi:10.6084/m9.figshare.24558217
Ryuk, D. K., Pelissari, D. M., Alves, K. B. A., Oliveira, P. B., Castro, M. C., Cohen, T., Sanchez, M., & Menzies, N. A. (2024) · Figshare · doi:10.6084/m9.figshare.25909945
Additional file 4 of Inadequate housing and pulmonary tuberculosis: a systematic review
Lee, J.-Y., Kwon, N., Goo, G.-Y., & Cho, S.-I. (2022) · Figshare · doi:10.6084/m9.figshare.19470442
Foster, N., Tadesse, A. W., McQuaid, C. F., Goscé, L., Abdurhman, T., Assefa, D., Bedru, A., Houben, R. M. G. J., van Kalmthout, K., Letta, T., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26584425
Feng, Z., Miao, Y., Peng, Y., Sun, F., Zhang, Y., Li, R., Ge, S., Chen, X., Song, L., Li, Y., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22790312
Li, W., Su, M., ZHang, W., Fan, X., Li, R., Gao, Y., & Wei, X. (2024) · Figshare · doi:10.6084/m9.figshare.26634648
Makabayi‐Mugabe, R., Musaazi, J., Zawedde‐Muyanja, S., Kizito, E., Fatta, K., Namwanje, H., Turyahabwe, S., & Nkolo, A. (2024) · Figshare · doi:10.6084/m9.figshare.26639208
Wang, N., Guo, L., Shewade, H. D., Thekkur, P., Zhang, H., Yuan, Y.-L., Wang, X.-M., Wang, X., Sun, M.-M., Huang, F., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14235075
Todowede, O. O., Afaq, S., Adhikary, A., Kanan, S., Shree, V., Jennings, H. M., Faisal, M. R., Nisar, Z., Khan, I., Desai, G., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23812383
Makabayi‐Mugabe, R., Musaazi, J., Zawedde‐Muyanja, S., Kizito, E., Fatta, K., Namwanje, H., Turyahabwe, S., & Nkolo, A. (2023) · Figshare · doi:10.6084/m9.figshare.24558083
Bartholomay, P., Pinheiro, R. S., Johansen, F. D. C., Pelissari, D. M., & de Araújo, W. N. (2021) · Figshare · doi:10.6084/m9.figshare.16779483
Law, S. J., Seepamore, B., Oxlade, O., Sikhakhane, N., Dawood, H., Chetty, S., Padayatchi, N., Menzies, D., & Daftary, A. (2021) · Figshare · doi:10.6084/m9.figshare.14615288
Wang, N., Guo, L., Shewade, H. D., Thekkur, P., Zhang, H., Yuan, Y.-L., Wang, X.-M., Wang, X., Sun, M.-M., Huang, F., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14235078
Wang, R., Liu, H., Zhang, Y., Lei, Q., Li, T., & Zheng, Y. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-025-11810-9
Dery, Z. M., Pagatpatan, C. P., & Bonifacio, M. C. (2026) · JBI Evidence Synthesis · doi:10.11124/jbies-25-00054 · Cited by 1
Kurnianta, P. D. M., Suwirtawati, N. P. D., & Dhrik, M. (2025) · Pharmacon Jurnal Farmasi Indonesia · doi:10.23917/pharmacon.v22i2.12652
“Prior studies confirm that non-adherence due to lengthy treatment regimens has contributed significantly to poor outcomes (Abdu & Walelgn, 2021; Alipanah et al., 2018; Lee et al., 2024).”
Rahayu, S. R., Nugroho, A., Ningrum, D. N. A., Merzistya, A. N. A., Wijayantiningrum, T., Simanjuntak, J. S., Maali, M. Z., Hafidh, K. A., Salsabila, A. P., Pranindita, S. K., et al. (2026) · Healthcare Informatics Research · doi:10.4258/hir.2026.32.1.4
“Therefore, tools that provide medication reminders are essential to support TB treatment and reduce non-compliance.”
Lin, X., Ibarz, D., Cebollada, A., Martı́n, C., Iglesias, M. J., & Samper, S. (2026) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofag079
“Known risk factors include HIV infection, smoking, diabetes, residual pulmonary cavitation, poor adherence to treatment, and the specific strain of M tuberculosis involved [10–14].”
Contribution des études observationnelles dans la méta-analyse
Cheurfa, C. (2023) · theses.fr (ABES) · doi:10.70675/ecaa782bz76f7z4c43za043ze1d3e0cfbfaa
Ducci, F., Bernardini, F. E., Lagi, F., Bresci, S., Lionetti, E., Bartoloni, A., & Mencarini, J. (2026) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2026.102965
Lipman, M. C. I., Abubakar, I., Campbell, C., Clarke, C. S., Copas, A. J., Costello, P., Darvell, M., Horne, R., Hunter, R. M., Jones, A. S. K., et al. (2025) · Health Technology Assessment · doi:10.3310/gjml0604
Kankawale, S., Chutke, A. P., & Kaur, N. (2026) · BMC Public Health · doi:10.1186/s12889-026-27448-4
“Similarly, social factors such as lack of support from friends and family, stigma, and discrimination, especially in individuals with comorbidities such as HIV, contribute to treatment non-adherence [8, 12].”
InfluentialGuzman, K. J., Wolf, A., Perumal, R., Lu, X., Boodhram, R., Seepamore, B., Reis, K., Amico, K. R., Friedland, G., Zelnick, J., et al. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13401-8
“Although interventions such as education, psychosocial support, and EDMs show promise, current global practices lack a systematic, targeted approach for delivering these supports to individuals most in need [11, 12].”
Zhong, X., Liu, K., Zhang, J., Tang, X., Lu, T., Chen, Q., Pang, J., Chen, R., Li, B., Ding, S., et al. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13480-7
“Treatment adherence (SHAP = 0.060) exhibited a protective effect, consistent with global TB control priorities [58].”
InfluentialDepressive Symptoms in Pediatric Tuberculosis: A Retrospective Two-Time-Point Observational Study
Mihailov, O. M., Stavăr-Matei, L., Țocu, G., Luțenco, V., Popovici, C. G., & Mihailov, R. (2026) · Diseases · doi:10.3390/diseases14050157
Sineke, N., Faye, L. M., Dlatu, N., Ombinda-Lemboumba, S. S., & Apalata, T. R. (2026) · Infectious Disease Reports · doi:10.3390/idr18050110
Richardson, S., Vorster, P., Burger, R., & Rieger, M. (2026) · JMIR Formative Research · doi:10.2196/85242
“Nonadherence to tuberculosis treatment remains a major barrier to disease control, driving higher tuberculosis incidence, the spread of drug-resistant strains, and poor treatment outcomes [11].”
Ntombela, N., Mabuto, T., Owczarzak, J., Charalambous, S., & Hoffmann, C. J. (2026) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580261421077
“24 In the South African context, a 2023 study found strong evidence that a differentiated service delivery model with curriculum and peer support designed specifically to address the needs of people with HIV returning from incarceration improved the primary outcome of enrollment in HIV treatment…”
Kwabla, M. P., Dormechele, W., Tuglo, L. S., Apenteng, O. O., Kye-Duodu, G., Osei, E., Der, J. B., Adusi-Poku, Y., & Baiden, F. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-13804-7
“Similarly, a systematic review by Alipanah et al. (2018) [14] emphasized that non-adherence to TB treatment and monitoring Geographic disparities in TB adherence, particularly between urban and rural areas, have been reported across Africa.”
Defining person-centred treatment support for multidrug-resistant TB: a discrete choice experiment
Kagujje, M., Mtumbi, G., Sikandangwa, M., Shatalimi, J., Muyoyeta, M., & Kerkhoff, A. D. (2026) · IJTLD OPEN · doi:10.5588/ijtldopen.25.0825
Patient-centered and technology-enabled strategies to improve tuberculosis treatment adherence
Muniyandi, M., Salam, S. A., & Nagarajan, K. (2026) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2026.2691181 · Cited by 1
“A systematic review showed that peer support interventions are associated with improved treatment adherence, reduced loss to follow-up, and better treatment outcomes, particularly among high-risk groups such as patients with prior default or DR-TB [26].”
Arifiani, M., & Cholisoh, Z. (2026) · Journal of Pharmaceutical And Sciences · doi:10.36490/journal-jps.com.v9i2.1629
Azhari, M., Isshiki, S., Horinouchi, R., Singgih, M., Arai, M., Garmana, A. N., Hartati, R., Hadisaputri, Y. E., Yuniarti, N., & Julianti, E. (2026) · Marine Drugs · doi:10.3390/md24070236
“However, the complexity and duration of treatment often result in poor adherence, relapse, and drug resistance [4,5].”
VASCONCELOS, A. R. G., Gonçalves, K. D. S. T., Dias, M. F. D. C., FÉLIX, J. T. B., Calixto, K. K. O., Carneiro, S. R., Albério, C. A. A., & Pinheiro, M. D. C. N. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-026-02502-9
“…revealed that inadequate adherence to tuberculosis treatment regimens resulted in reduced culture conversion, indicating the persistence of Mycobacterium tuberculosis transmission within the community and the emergence and expansion of resistance to standard thera - peutic regimens [ 33 ].”
Vilbrun, S. C., Braccio, C., Augustin, G. M., François, K., Richard, M., Joseph, P., Harris, J. B., & Charles, M. (2026) · PLOS Global Public Health · doi:10.1371/journal.pgph.0006209
“Disruptions in TB diagnostic and treatment services can lead to treatment failure, increased mortality, and higher TB transmission rates within communities [7].”
Torres, A., González, P., Fors, M. M., & Trujillo, G. (2026) · Diseases · doi:10.3390/diseases14080267
“Moreover, the absence of quantitative synthesis precludes estimation of effect sizes and limits direct comparison of the magnitude of associations across studies.”
Ngari, M. M., Chea, S. K., Mwamsidu, C. M., Sanga, D., Katana, G. G., Thuva, F. M., Onyango, G. U., Kamau, C., & Abdullahi, O. A. (2026) · medRxiv · doi:10.64898/2026.07.28.26359180
Adejumo, O. A., Jinabhai, C., & Haffejee, F. (2026) · BMC Infectious Diseases · doi:10.1186/s12879-026-14163-z
He, W., Liao, J., Pan, H., Zhang, L., Li, X., Huang, J., Liu, Z., Ke, X., Li, J., Li, X., et al. (2026) · Digital Health · doi:10.1177/20552076261472569
“30,31 34 In parallel, scalable digital approaches are increasingly explored to strengthen continuity of care after discharge, particularly in high-burden and resource-constrained settings.”
Kalottee, B., Nuken, A., Kalra, A., Chadha, S. S., Mannan, S., Singh, M., Solanki, H., Taralekar, R., Yassin, M. A., Restrepo, N., et al. (2026) · IJTLD OPEN · doi:10.5588/ijtldopen.26.0168
Karuga, S., Were, V., & Mambo, S. (2026) · Cureus · doi:10.7759/cureus.114392
“However, these associations have not been consistent across settings, suggesting that behavioral determinants are context-specific and should be investigated within local populations [6-11].”
Umoh, P., Sanni, O. F., Emenike, K., Abang, R., Amechi, P., & Ochonye, B. B. (2026) · Journal of Public Health and Primary Care · doi:10.4103/jphpc.jphpc_29_25
Treatment Adherence in Patients with Tuberculosis: An Integrative Review
Natalia, G. D., Irwan, A. M., & Buckenmeyer, A. C. (2025) · Journal of Education and Community Health · doi:10.34172/jech.3160
“Alipanah et al, Syahrul et al, and Zuraida et al (14-16) demonstrated that increased adherence to TB treatment can be achieved through diverse approaches, including education, counseling, incentives, facility support, psychological interventions, reminders, monitoring, and digital technology.”
Malnutrition and its determinants among tuberculosis patients in Lahore, Pakistan
Hasan, M. K., & Tariq, K. (2025) · doi:10.58398/0007.000005
Syahputra, A. G., Machmud, R., & Kasra, K. (2026) · Journal of Pharmaceutical And Sciences · doi:10.36490/journal-jps.com.v9i3.1723
Wiratama, B. S., Susaldi, S., Lesmana, M. H. S., Damanik, M. R. M., Prasetya, G., Paramastri, R., Pratiwi, W. R., & Sadewa, A. H. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1958725
“…modi fi able through health education, psychological support, nutritional assistance, transport support, community-based treatment program, and social protection policies (Munro et al., 2007; Lönnroth et al., 2009; Hargreaves et al., 2011; Volmink and Garner, 2026; Alipanah et al., 2018).”
Vera-Ponce, V. J., Ballena-Caicedo, J., Vasquez, N. J. C., García-Rodríguez, M. D., Ynga, J. A. Y., & Zuzunaga-Montoya, F. E. (2026) · Infectious Disease Reports · doi:10.3390/idr18050108
“Evidence from adherence interventions suggests that integrated packages of education, counseling, incentives, psychological support, reminders, and tracing may improve outcomes, whereas direct observation alone is insufficient [29,30].”
Guo, X., Bai, J., Wan, X., Takiff, H. E., Yang, Y., Wang, C., Huang, S., Ma, C., & Liu, S. (2026) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed11100272
“The prolonged treatment for TB, currently a minimum of 4–6 months, often leads to patients dropping out during self-management of medication, which can result in treatment failure, drug resistance and on-going TB transmission [2,3].”
Lu, X., Zelnick, J., Zhao, M., Cummings, M., Wolf, A., Guzman, K. J., Nyilana, H., Perumal, R., Amico, K. R., Reis, K., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0355696
“This observation aligns with behavioral adherence models emphasizing reinforcement, accountability, direct support, and sustained engagement over discrete informational content [18].”
Metadata
- Authors
- Alipanah, N., Jarlsberg, L., Miller, C., Linh, N. N., Falzon, D., Jaramillo, E., & Nahid, P.
- Affiliations
- University of California, San Francisco (US)
- World Health Organization (CH)
- Corresponding author
- Nahid, Payam
- Venue
- PLOS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-07-03
- Volume
- 15
- Issue
- 7
- Pages
- e1002595
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC6029765
- OpenAlex
- W2810683857
- Cited by
- 503
- References
- 156
- Citations by year
- 2026: 48 · 2025: 75 · 2024: 79 · 2023: 88 · 2022: 75 · 2021: 67 · 2020: 42 · 2019: 26 · 2018: 3
- FWCI
- 5.09
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (publishedVersion)
- eScholarship (California Digital Library) (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Funders
- World Health Organization
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Health Professions › General Health Professions › Mobile Health and mHealth Applications
- Keywords
- tuberculosis, medication adherence, directly observed therapy, drug-resistant tuberculosis, self-administered therapy, sputum smear conversion, treatment failure, drug resistance development, incentives, patient education, video-observed therapy, mobile phone reminders, treatment success, relapse, transmission risk, multidrug therapy, patient-provider relationship
- MeSH terms
- Adolescent, Adult, Antitubercular Agents, Attitude of Health Personnel, Child, Child, Preschool, Health Personnel, Humans, Infant, Infant, Newborn, Health Knowledge, Attitudes, Practice, Patient Education as Topic, Risk Factors, Self Care, Tuberculosis, Video Recording, Randomized Controlled Trials as Topic, Treatment Outcome, Telemedicine, Directly Observed Therapy, Cell Phone, Medication Adherence, Text Messaging, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.